(Q45760750)

15 December 2017

title

Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs (English)

1 reference

15 December 2017

author name string

S Kommareddy

1

1 reference

15 December 2017

B C Baudner

2

1 reference

15 December 2017

A Bonificio

3

1 reference

15 December 2017

S Gallorini

4

1 reference

15 December 2017

G Palladino

5

1 reference

15 December 2017

A S Determan

6

1 reference

15 December 2017

D M Dohmeier

7

1 reference

15 December 2017

K D Kroells

8

1 reference

15 December 2017

J R Sternjohn

9

1 reference

15 December 2017

M Singh

10

1 reference

15 December 2017

P R Dormitzer

11

1 reference

15 December 2017

K J Hansen

12

1 reference

15 December 2017

D T O'Hagan

13

1 reference

15 December 2017

language of work or name

English

0 references

publication date

8 February 2013

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

31

1 reference

15 December 2017

issue

34

1 reference

15 December 2017

page(s)

3435-3441

1 reference

15 December 2017

Economic costs of influenza-related work absenteeism.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

The economic impact of pandemic influenza in the United States: priorities for intervention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Innate immune evasion strategies of influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Needle-free influenza vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

New technologies for influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

MF59 adjuvant: the best insurance against influenza strain diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Emulsion-based adjuvants for influenza vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

A systematic review of intradermal influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Coated microneedles for transdermal delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Dissolving polymer microneedle patches for influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Targeted, Needle-Free Vaccinations in Skin using Multilayered, Densely-Packed Dissolving Microprojection Arrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Painless drug delivery through microneedle-based transdermal patches featuring active infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Stability of influenza vaccine coated onto microneedles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Microneedles in clinical practice--an exploratory study into the opinions of healthcare professionals and the public

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Preparation of highly concentrated influenza vaccine for use in novel delivery approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Influenza virus surveillance, vaccine strain selection, and manufacture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.050

10.1016/J.VACCINE.2013.01.050

7 January 2021

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

23398932

1 reference

15 December 2017